Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | F-1 | tm2036979-2_f1.htm | F-1 | 5335427 |
2 | EXHIBIT 1.1 | tm2036979d3_ex1-1.htm | EX-1.1 | 217414 |
3 | EXHIBIT 3.4 | tm2036979d3_ex3-4.htm | EX-3.4 | 25183 |
4 | EXHIBIT 5.1 | tm2036979d3_ex5-1.htm | EX-5.1 | 48528 |
5 | EXHIBIT 8.1 | tm2036979d3_ex8-1.htm | EX-8.1 | 20995 |
6 | EXHIBIT 8.2 | tm2036979d3_ex8-2.htm | EX-8.2 | 19736 |
7 | EXHIBIT 8.3 | tm2036979d3_ex8-3.htm | EX-8.3 | 6628 |
8 | EX-10.42 | tm2036979d3_ex10-42.htm | EX-10.42 | 21991 |
9 | EX-10.43 | tm2036979d3_ex10-43.htm | EX-10.43 | 16759 |
10 | EXHIBIT 10.44 | tm2036979d3_ex10-44.htm | EX-10.44 | 32250 |
11 | EXHIBIT 10.46 | tm2036979d3_ex10-46.htm | EX-10.46 | 19500 |
12 | EXHIBIT 10.47 | tm2036979d3_ex10-47.htm | EX-10.47 | 72284 |
13 | EXHIBIT 10.48 | tm2036979d3_ex10-48.htm | EX-10.48 | 43145 |
14 | EXHIBIT 23.1 | tm2036979d3_ex23-1.htm | EX-23.1 | 2150 |
15 | GRAPHIC | lg_curevac-4c.jpg | GRAPHIC | 41107 |
16 | GRAPHIC | tm2036979d1-bc_activ4clr.jpg | GRAPHIC | 83682 |
17 | GRAPHIC | tm2036979d1-bc_dose4clr.jpg | GRAPHIC | 237079 |
18 | GRAPHIC | tm2036979d1-bc_higher4clr.jpg | GRAPHIC | 55405 |
19 | GRAPHIC | tm2036979d1-bc_impac4clr.jpg | GRAPHIC | 158486 |
20 | GRAPHIC | tm2036979d1-bc_lvl4clr.jpg | GRAPHIC | 51034 |
21 | GRAPHIC | tm2036979d1-bc_mice4clr.jpg | GRAPHIC | 119710 |
22 | GRAPHIC | tm2036979d1-bc_mild4clr.jpg | GRAPHIC | 120001 |
23 | GRAPHIC | tm2036979d1-bc_mn4clr.jpg | GRAPHIC | 1973537 |
24 | GRAPHIC | tm2036979d1-bc_mrna4clr.jpg | GRAPHIC | 49377 |
25 | GRAPHIC | tm2036979d1-bc_optimi4clr.jpg | GRAPHIC | 211681 |
26 | GRAPHIC | tm2036979d1-bc_orf4clr.jpg | GRAPHIC | 55752 |
27 | GRAPHIC | tm2036979d1-bc_perli4clr.jpg | GRAPHIC | 148385 |
28 | GRAPHIC | tm2036979d1-bc_protein4clr.jpg | GRAPHIC | 70518 |
29 | GRAPHIC | tm2036979d1-bc_rdb4clr.jpg | GRAPHIC | 111129 |
30 | GRAPHIC | tm2036979d1-bc_sars4clr.jpg | GRAPHIC | 140220 |
31 | GRAPHIC | tm2036979d1-bc_serum4clr.jpg | GRAPHIC | 151837 |
32 | GRAPHIC | tm2036979d1-bc_spik4clr.jpg | GRAPHIC | 152792 |
33 | GRAPHIC | tm2036979d1-bc_viral4clr.jpg | GRAPHIC | 120555 |
34 | GRAPHIC | tm2036979d1-bc_vnt4clr.jpg | GRAPHIC | 72399 |
35 | GRAPHIC | tm2036979d1-fc_cv7bwlr.jpg | GRAPHIC | 74602 |
36 | GRAPHIC | tm2036979d1-lc_absco4clr.jpg | GRAPHIC | 82426 |
37 | GRAPHIC | tm2036979d1-lc_amin4clr.jpg | GRAPHIC | 107032 |
38 | GRAPHIC | tm2036979d1-lc_area4clr.jpg | GRAPHIC | 60787 |
39 | GRAPHIC | tm2036979d1-lc_boos4clr.jpg | GRAPHIC | 2051098 |
40 | GRAPHIC | tm2036979d1-lc_cone4clr.jpg | GRAPHIC | 84630 |
41 | GRAPHIC | tm2036979d1-lc_cv7024clr.jpg | GRAPHIC | 122178 |
42 | GRAPHIC | tm2036979d1-lc_cv7204clr.jpg | GRAPHIC | 88530 |
43 | GRAPHIC | tm2036979d1-lc_design4clr.jpg | GRAPHIC | 114631 |
44 | GRAPHIC | tm2036979d1-lc_exten4clr.jpg | GRAPHIC | 62566 |
45 | GRAPHIC | tm2036979d1-lc_growth4clr.jpg | GRAPHIC | 64603 |
46 | GRAPHIC | tm2036979d1-lc_improv4clr.jpg | GRAPHIC | 59051 |
47 | GRAPHIC | tm2036979d1-lc_live4clr.jpg | GRAPHIC | 128637 |
48 | GRAPHIC | tm2036979d1-lc_lnp4clr.jpg | GRAPHIC | 93924 |
49 | GRAPHIC | tm2036979d1-lc_surv4clr.jpg | GRAPHIC | 64624 |
50 | GRAPHIC | tm2036979d1-lc_surviv4clr.jpg | GRAPHIC | 102481 |
51 | GRAPHIC | tm2036979d1-lc_total4clr.jpg | GRAPHIC | 59345 |
52 | GRAPHIC | tm2036979d1-lc_tumor4clr.jpg | GRAPHIC | 86892 |
53 | GRAPHIC | tm2036979d1-pht_bio4clr.jpg | GRAPHIC | 65084 |
54 | GRAPHIC | tm2036979d1-pht_body4clr.jpg | GRAPHIC | 172298 |
55 | GRAPHIC | tm2036979d1-pht_chara4clr.jpg | GRAPHIC | 282414 |
56 | GRAPHIC | tm2036979d1-pht_class4clr.jpg | GRAPHIC | 90676 |
57 | GRAPHIC | tm2036979d1-pht_cold4clr.jpg | GRAPHIC | 316685 |
58 | GRAPHIC | tm2036979d1-pht_combain4clr.jpg | GRAPHIC | 78138 |
59 | GRAPHIC | tm2036979d1-pht_cvcm4clr.jpg | GRAPHIC | 125397 |
60 | GRAPHIC | tm2036979d1-pht_design4clr.jpg | GRAPHIC | 126388 |
61 | GRAPHIC | tm2036979d1-pht_divers4clr.jpg | GRAPHIC | 203003 |
62 | GRAPHIC | tm2036979d1-pht_formula4clr.jpg | GRAPHIC | 227251 |
63 | GRAPHIC | tm2036979d1-pht_gmb4clr.jpg | GRAPHIC | 154195 |
64 | GRAPHIC | tm2036979d1-pht_mela4clr.jpg | GRAPHIC | 150150 |
65 | GRAPHIC | tm2036979d1-pht_metas4clr.jpg | GRAPHIC | 152863 |
66 | GRAPHIC | tm2036979d1-pht_muscle4clr.jpg | GRAPHIC | 332872 |
67 | GRAPHIC | tm2036979d1-pht_number4clr.jpg | GRAPHIC | 138931 |
68 | GRAPHIC | tm2036979d1-pht_option4clr.jpg | GRAPHIC | 173617 |
69 | GRAPHIC | tm2036979d1-pht_perfer4clr.jpg | GRAPHIC | 391383 |
70 | GRAPHIC | tm2036979d1-pht_pertre4clr.jpg | GRAPHIC | 93746 |
71 | GRAPHIC | tm2036979d1-pht_recis4clr.jpg | GRAPHIC | 213747 |
72 | GRAPHIC | tm2036979d1-pht_rna4clr.jpg | GRAPHIC | 122702 |
73 | GRAPHIC | tm2036979d1-pht_role4clr.jpg | GRAPHIC | 196459 |
74 | GRAPHIC | tm2036979d1-pht_sub4clr.jpg | GRAPHIC | 101047 |
75 | GRAPHIC | tm2036979d1-pht_transis4clr.jpg | GRAPHIC | 246006 |
76 | GRAPHIC | tm2036979d1-pht_treat4clr.jpg | GRAPHIC | 138741 |
77 | GRAPHIC | tm2036979d1-pht_unmodiclr.jpg | GRAPHIC | 135515 |
78 | GRAPHIC | tm2036979d1-pht_vaccin4clr.jpg | GRAPHIC | 82908 |
79 | GRAPHIC | tm2036979d2-bc_vnt4clr.jpg | GRAPHIC | 117473 |
80 | GRAPHIC | tm2036979d2-lc_mrnavac14clr.jpg | GRAPHIC | 161352 |
81 | GRAPHIC | tm2036979d2-lc_mrnavac4clr.jpg | GRAPHIC | 220328 |
82 | GRAPHIC | tm2036979d2-lc_sars14clr.jpg | GRAPHIC | 104781 |
83 | GRAPHIC | tm2036979d2-lc_sars24clr.jpg | GRAPHIC | 106243 |
84 | GRAPHIC | tm2036979d2-lc_sars34clr.jpg | GRAPHIC | 106848 |
85 | GRAPHIC | tm2036979d2-pht_ident4clr.jpg | GRAPHIC | 162405 |
86 | GRAPHIC | tm2036979d2-pht_immune4c.jpg | GRAPHIC | 154562 |
87 | GRAPHIC | tm2036979d2-pht_product4c.jpg | GRAPHIC | 1751962 |
88 | GRAPHIC | tm2036979d3_10-43img01.jpg | GRAPHIC | 10171 |
89 | GRAPHIC | tm2036979d3_10-43img02.jpg | GRAPHIC | 106870 |
90 | GRAPHIC | tm2036979d3_10-43img03.jpg | GRAPHIC | 120900 |
91 | GRAPHIC | tm2036979d3_ex10-48img001.jpg | GRAPHIC | 2590 |
92 | GRAPHIC | tm2036979d3_ex8-1img001.jpg | GRAPHIC | 7912 |
93 | GRAPHIC | tm2036979d3_ex8-2img001.jpg | GRAPHIC | 2749 |
94 | GRAPHIC | tm2036979d3_ex8-2img002.jpg | GRAPHIC | 3881 |
95 | GRAPHIC | tm2036979d3_ex8-2img003.jpg | GRAPHIC | 1760 |
96 | GRAPHIC | tm2036979d3_ex5-1img01.jpg | GRAPHIC | 5042 |
97 | GRAPHIC | tm2036979d3_ex8-1img002.jpg | GRAPHIC | 5335 |
98 | GRAPHIC | tm2036979d3_ex3-4img001.jpg | GRAPHIC | 2844 |
Complete submission text file | 0001104659-21-007168.txt | 26762206 |
IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-252391 | Film No.: 21549818
SIC: 2834 Pharmaceutical Preparations